SHINE Medical Technologies, a medical isotope company developing technology that originated from University of Wisconsin–Madison research, has signed a $125 million term sheet that represents a massive step in bringing an important medical advance to market.
Author: Brian Mattmiller
Bill Swisher joins Morgridge as Chief Development Officer
Bill Swisher, the assistant vice president for corporate and institutional partnerships at Carnegie Mellon University (CMU), has been named the new chief development officer of the Morgridge Institute for Research.
‘Tissue chip’ offers better approach to screen neural toxins
A multidisciplinary team at the University of Wisconsin–Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that may harm human development.
Andreas Velten: Taking imaging to new extremes
Unlike many of us, Andreas Velten loves working in windowless rooms. His research tools are shrouded in sealed black boxes to keep out unwanted light. He’s been known to cover red building exit signs to extinguish any trace of visual noise.
Targeting HIV with live cell imaging
Using an imaging technique that illuminates viral behavior within live cells, a team of scientists at the University of Wisconsin–Madison and the Morgridge Institute for Research are identifying new targets to derail the disease-spreading machinery of human immunodeficiency virus (HIV).